Abstract
Background: The Psychosocial Index (PSI) is a self-rating scale based on clinimetric principles that is simple to use in a busy clinical setting. It can be integrated by observer-rated clinical judgment, providing a first-line, comprehensive assessment of stress, well-being, distress, illness behavior, and quality of life. By calculation of scores, it can be used for conventional psychological measurements. Its clinical applications and clinimetric properties are reviewed. The present version of the PSI has been slightly revised. In addition, a modified version for use in adolescents and young adults (PSI-Young; PSI-Y) is also included. Methods: Articles that involved the use of the PSI were identified by searching the Web of Science database from 1998 to February 2016 and by a manual search of the literature. Results: A total of 20 studies reporting results from the use of PSI were included. The PSI has been employed in various clinical populations in different countries and showed high sensitivity. It significantly discriminated varying degrees of psychosocial impairment in different populations. When subjects were identified by categorical criteria (presence of allostatic overload, psychosomatic syndromes, psychiatric disorders), the PSI scores were significantly different across subgroups. Conclusions: In clinical practice, scanning the list of symptoms allows clinicians to assess rapidly which symptoms and problems are perceived as most troublesome. In research settings, the use of scores makes the PSI a valid and sensitive tool in differentiating levels of psychosocial variables among groups.
Introduction
The Psychosocial Index (PSI) was introduced by Sonino and Fava [1] in 1998 mainly to provide clinicians with a simple screening tool for stress and other psychosocial dimensions in a busy clinical practice. By the evaluation of scores, it can be employed in research settings as well. It was developed according to clinimetric principles. The domain of clinimetrics is concerned with quantitative methods in the collection and analysis of clinical phenomena, such as type, severity and sequence of symptoms, problems of functional capacity, and reason for medical decisions, with emphasis on clinical judgment [2, 3, 4, 5, 6, 7, 8]. The clinimetric criteria for evaluating the clinical validity of a scale differ from those of the standard psychometric analyses [4, 9]. An essential difference is concerned with the discrimination properties (responsiveness/sensitivity) of an index, defined as the ability to differentiate between patients and controls. Unlike in psychometrics, homogeneity of components is not requested and single items may be weighed in different ways. What matters is the capacity of an index to discriminate between different groups of subjects and to reflect changes in experimental settings such as drug trials. In psychometrics, the same properties that give a scale a high score for homogeneity may obscure its ability to detect change, and redundant scale items may increase homogeneity but decrease sensitivity [4]. A high correlation is often regarded as evidence that the two scales measure the same factor. However, a high correlation does not indicate similar sensitivity: a common content of two scales may insure a high positive correlation between them, but the items they do not share may be important in determining their sensitivity [4]. A test of sensitivity is provided by the capacity of an index to discriminate between subgroups of subjects with the same disease (e.g., inpatients and outpatients with depression) [10].
Based on insights derived from studies performed in the past two decades, we here report a slightly modified version of the PSI and review the available data concerning its clinimetric properties and clinical applications.
Description of the PSI
This self-rating questionnaire (Appendix 1) includes 55 items, most of which are derived from previously validated instruments. Thirty-five items (1-20 and 37-51) were selected from the 118 of Kellner's Screening List for Psychosocial Problems [11], eliminating all sources of redundancy. They constitute the sociodemographic and clinical data section, the psychological distress scale and part of the stress scale. The latter has been integrated with 10 items (21-30) derived from the Wheatley Stress Profile [12]. Six questions (31-36) were derived from Ryff's Psychological Well-Being scales [13] and constitute the well-being section. Three questions (52-54) were selected from Kellner's Illness Attitude Scales [14, 15] and compose the abnormal illness behavior scale.
The following domains are covered:
(a) Sociodemographic and clinical data:this part (items 1-12) includes largely routine information about medical and psychiatric history, the patient's family, employment and habits. It may alert clinicians to some threats to health, such as alcohol or drug use.
(b) Stress:this section (items 13-20 and 22-30) is an integration of both perceived and objective stress, life events and chronic stress. It consists of 17 questions with a total score ranging from 0 to 17. These questions contain essential information for case identification of allostatic overload [16].
(c) Well-being: this section (items 31-36) covers different areas of well-being, i.e., positive relations with others (items 31, 32), environmental mastery (items 33, 34) and autonomy (items 35, 36), with a score ranging from 0 to 6.
(d) Psychological distress:this section (items 37-51) consists of a checklist of symptoms addressing sleep disturbances, somatization, anxiety, depression and irritability. The total score may range from 0 to 45. Questions 37-40 refer to sleep disturbances (range 0-12) and may also be scored separately from the other questions.
(e) Abnormal illness behavior:it allows the assessment of hypochondriacal beliefs and bodily preoccupations (items 52-54). The total score may range from 0 to 9.
(f) Quality of life (item 55): a simple direct question on quality of life is included, following the recommendation of Gill and Feinstein [17]. The score ranges from 0 to 4. The scores concerned with psychological well-being (0-6) and quality of life (0-4) can be added for obtaining a global well-being score (0-10).
The self-rating questionnaire (Appendix 1) provides a dimensional assessment of psychosocial features. Some questions involve specific responses, most require a yes/no answer, while others are rated on a Likert scale (0-3, from ‘not at all' to ‘a great deal'); 1 item, quality of life, has 5 possible choices, from excellent to awful. For detailed scoring instructions, see Appendix 3. The PSI is not designed to calculate a total score.
A 51-item modified version of the PSI has recently been developed for assessing psychosocial factors among adolescents and young adults up to 21 years of age (PSI-Young; PSI-Y), with particular reference to studying activities, educational setting, peer relationships, and family environment (see online suppl. table 1, 2; see www.karger.com/doi/10.1159/000447760 for all online suppl. material). It has been used in a study aimed at providing a psychological characterization of hyperandrogenic states among late adolescent and young women [18].
The observer rating of the PSI (Appendix 2), by visually scanning the patient self-rated responses, allows the clinician to evaluate the PSI subscales directly on a 5-point Likert scale. Observer-rating scores may range from highly stressful life to nonstressful life for stress; from excellent to absent for well-being; from incapacitating to absent for psychological distress and abnormal illness behavior. Observer rating does not provide a total score. Question 55 on quality of life is self-rated by the patient, with no need for external judgment by the observer.
Methods
Data Source
Articles citing the original PSI reference [1] were identified by searching the Web of Science database, from 1998 to February 2016. In addition, potentially relevant papers were searched manually.
Study Selection
Two investigators (A.P. and E.O.) carried out the search independently; disagreements were resolved by consensus among raters and one senior investigator (N.S.). Articles were considered to be eligible if they reported research data with regard to administration of the PSI.
Data Extraction
Data were independently extracted with the use of a precoded form. The following data were extracted from the included studies: purpose of the study, number of subjects, design, tools administered and findings (online suppl. table 3).
Results
Characteristics of Included Studies
The literature search identified 37 relevant articles. Of these, 17 were excluded: 15 studies only cited the PSI and 2 were duplicates. A total of 20 investigations were included in the review (for a flow diagram of the search, see online suppl. fig. 1). Details of the 20 studies are summarized in online supplementary table 3 and the main findings are outlined here.
Use for Clinical Assessment
- The interrater reliability of the observer-rating part of the PSI (Appendix 2) was assessed in subjects with functional medical disorders evaluated by an internist and a psychiatrist. The PSI observer-rating part showed high interrater reliability, with intraclass correlation coefficients of 0.88 for rating stress, 0.94 for well-being, 0.89 for psychosocial distress, and 0.90 for illness behavior [1].
- The PSI was used to aid the clinical interview in three investigations concerned with the assessment of allostatic overload in the general population [19], in atrial fibrillation [20], and in congestive heart failure [21]. In these three studies, individuals who displayed allostatic overload were found to report significantly more psychological distress than subjects without allostatic overload. In another investigation [22], the determination of allostatic overload in healthy subjects was based on the responses to the PSI in conjunction with additional self-rated measures. This study showed that individuals with an allostatic overload differed from those without it in levels of some biological parameters [22].
- The PSI has been administered as a screening tool for psychosocial factors in a psychoneuroendocrinology clinic [23]. Data gathered from the PSI were used to evaluate the need of patients for further psychological assessments and to plan therapeutic strategies.
Use of Self-Rating Scores
The PSI consists of items of validated scales and its sections can thus be used for conventional psychological measurements.
- In clinical endocrinology, it detected significantly higher levels of stress and psychological distress, impaired well-being and maladaptive illness behavior in patients with pituitary disease compared to healthy controls [24]. The sensitivity of the PSI was also confirmed when a population suffering from a wide range of endocrine conditions [25] was analyzed as to the presence of psychiatric disorders according to the DSM-IV [26] and/or psychosomatic syndromes according to the Diagnostic Criteria for Psychosomatic Research (DCPR) [27, 28, 29]. Psychological distress identified by semistructured research interviews was confirmed by PSI self-rated scores. Such findings were similar to those obtained in a community sample [30], where significantly higher scores in the scales of stress and psychological distress and significantly lower scores in well-being were found in subjects with DCPR syndromes compared to those without. In another study [31], hypertensive subjects with primary aldosteronism showed significantly higher levels of stress and psychological distress and lower levels of well-being as compared to normotensive controls. Furthermore, patients with primary aldosteronism displayed significantly higher scores on PSI stress compared to patients with essential hypertension. Finally, in a recent study [18], adolescent females affected by isolated clinical hyperandrogenism (i.e., hirsutism) reported significantly lower levels of PSI-Y well-being and quality of life compared to their healthy counterparts.
- As to blood pressure, the PSI was used to evaluate the influence of psychosocial factors on changes in daytime/nighttime blood pressure rhythm in normotensive and hypertensive subjects [32]. In this investigation, the items concerned with sleep disturbances were analyzed separately from the section of psychological distress. Patients with essential hypertension who had no nocturnal fall in blood pressure had a significantly worse quality of sleep compared to those who had the blood pressure physiological decline. Further, there were significant correlations between the amount of stress and nocturnal blood pressure levels in subjects with normal blood pressure [32]. In another study on hypertensive subjects [33], participants were classified into three subgroups (affective disturbances, alexithymia, and somatization) according to a cluster analysis based on DSM-IV [26] and DCPR [27, 28, 29] diagnoses. The combined PSI score of stress and psychological distress discriminated among these subgroups. Patients in the somatization group reported the highest combined score and those in the alexithymia group showed the lowest score.
Subjects with medically unexplained syncope showed significantly higher levels of PSI psychological distress and lower levels of psychological well-being, as compared to individuals with vasovagal syncope [34]. This finding is consistent with previous studies [35, 36].
- In cardiology, a longitudinal study [37] evaluated the psychological status of patients who underwent coronary artery bypass grafting at 1 month and at 6-8 years after surgery. The PSI section of abnormal illness behavior sensitively detected a decrease in worry about physical conditions when the acute phase of the illness abated. In patients with recent myocardial infarction who participated in a cardiac rehabilitation program [38], combined PSI scores did not predict subsequent coronary events (death, myocardial infarction, or angina pectoris). Among patients with congestive heart failure [39], participants with DCPR diagnoses had significantly higher scores on the PSI sections of stress and psychological distress compared to those with no diagnoses. In patients with an implantable cardioverter defibrillator [40], the PSI was used to monitor psychological variables up to 1 year of follow-up.
- Breast cancer survivors showed significantly higher levels of PSI psychological distress as compared to healthy controls reporting negative events other than cancer [41]. In addition, breast cancer survivors with a high posttraumatic growth score reported significantly less psychological distress compared to those with a low score. Posttraumatic growth is a feature that indicates positive changes in many life domains as a result of the personal, cognitive and emotional efforts in dealing with traumatic events [42].
- In the setting of a highly pathogenic avian influenza in Nigeria, people whose farms had suffered avian influenza H5N1 outbreaks had significantly higher PSI scores of abnormal illness behavior and stress than those whose farms had not been affected by the outbreak epidemics in poultry [43].
Discussion
The self-rating PSI may be employed in different ways: (a) as a screening tool in the setting of medical evaluation and interviewing; (b) it can be integrated with clinical judgment by applying a simple observer-rated score, and (c) by calculation of scores, it can be used for conventional psychological measurements [1]. In the studies that we have reviewed, all these modalities have been used.
In clinical assessment, using the PSI allows to scan the list rapidly to determine which psychological and social problems, and/or psychiatric symptoms the patient finds distressing. By simply scanning the answers, the clinician may understand the degree of stress, well-being, psychological distress, illness behavior and quality of life. It may provide preliminary ground for specific questions as to psychological distress during medical examination and interviewing, leading to diagnostic and therapeutic decisions or specialist referral [1, 23].
The simple observer-rating score, which emphasizes clinical judgment [4], may result particularly useful for clinical practice, due to the short time that is requested for this rating. These issues are all of considerable importance for primary care, where psychological distress is common but often remains undetected and inadequately managed [44].
The PSI has some unique properties compared to other scales that are available [3]. According to clinimetric principles, items that were included were selected on the basis of the amount of clinical information they carried. For instance, as to psychological distress, there are 4 items concerned with sleep (items 37-40, Appendix 1), that cover difficulties falling asleep, restless sleep, early morning awakening and feeling tired on waking up. These are 4 key areas in the determination of sleep quality [45, 46].
The specific contribution of the PSI as to main clinical domains deserves to be discussed.
Allostatic Load
Due to its ability to provide a quick but comprehensive evaluation of stress, the PSI is a very suitable instrument for the screening of allostatic overload, especially in medical settings [20, 21, 22, 47]. Clinimetric criteria for the determination of allostatic overload include: (a) the presence of a stressor exceeding individual coping skills, and (b) clinical manifestations of distress, which may range from psychiatric to psychosomatic/subclinical symptoms, and from impairment in social and occupational functioning to decrease in well-being [16].
Well-Being
Stress, psychological distress and illness behavior may be linked to the individual's potential for coping and social support (well-being). Several studies have suggested that psychological well-being plays a buffering role in coping with stress and has a favorable impact on disease course [13, 45, 48, 49].
Psychological Distress
Psychological distress is strongly associated with medical conditions. Depression, in particular, may affect functioning, quality of life and health care utilization [50, 51]. However, there is emerging awareness that also psychological symptoms that do not reach the threshold of a psychiatric disorder may affect quality of life and entail pathophysiological and therapeutic implications [29].
Illness Behavior
The concept of illness behavior was introduced to indicate the ways in which given symptoms may be perceived, evaluated and acted upon at an individual level [52]. Illness behavior may greatly vary according to illness-related, patient-related and doctor-related variables and their complex interactions. In the past decades, important lines of research have been concerned with illness perception, frequent attendance of medical facilities, health-care-seeking behavior, treatment-seeking behavior, delay in seeking treatment, and treatment adherence [53, 54, 55]. According to this review, the questions on abnormal illness behavior helped to discriminate between subgroups [24, 43]. They might show high sensitivity in populations where hypochondriasis or functional medical disorders are predominant aspects [15].
Quality of Life
Since measures of disease status alone are insufficient to describe the burden of illness, it has been proposed that the evaluation of disease outcomes by the clinician be integrated with appraisal of health and quality of life by the patient [56, 57]. A related aspect concerns patient-reported outcomes, any report coming directly from patients without interpretation by physicians or others about how they function or feel in relation to a health condition or its therapy [58, 59]. The PSI provides a global measure of well-being integrated with that of quality of life. The evidence from the studies included in this review suggests that well-being and quality of life are compromised in patients with cardiovascular and endocrine disorders [18, 24, 31, 32, 34].
Calculation of scores provides conventional psychological measurements. The findings suggest a high sensitivity of the PSI self-rating questionnaire. In all studies, the PSI displayed good sensitivity in discriminating between patients and controls. In particular, there were significant differences in stress, psychological distress and well-being between patients affected by endocrine disease, cardiovascular disorders, breast cancer and their matched healthy controls. In addition, the PSI discriminated between subjects with and without allostatic overload [19, 20, 21, 22].
Another important clinimetric characteristic is incremental validity [4, 60]: each distinct aspect of measurement should deliver a unique increase in information in order to qualify for inclusion. Often a number of scales are used under the misguided assumption that nothing will be missed. On the contrary, violation of the concept of incremental validity leads to conflicting results [4]. Each of the five PSI sections yields an incremental increase in information that provides a comprehensive assessment of the main psychosomatic domains [16, 50, 61], where elements of redundancy were eliminated.
In conclusion, the PSI constitutes a clinimetric tool of high clinical utility and allows a comprehensive, sensitive appraisal of psychosomatic domains in different populations.